International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors
Harvard University · Brigham and Women's Hospital · +6 more institutions
Abstract
No abstract available for this paper.
Citation impact
- FWCI
- 16.69
- Percentile
- 100%
- References
- 321
Authors
16- LMLiliane MichalikCorresponding
Harvard University, Brigham and Women's Hospital, University of Lausanne, Dana-Farber Cancer Institute, Center for Cancer Research, Inserm, Ninewells Hospital
- JAJohan Auwerx
Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard University, Inserm, Center for Cancer Research, University of Lausanne, Ninewells Hospital, Institut de génétique et de biologie moléculaire et cellulaire
- JPJoel P. Berger
Inserm, Institut de génétique et de biologie moléculaire et cellulaire, University of Lausanne, Dana-Farber Cancer Institute, Harvard University, Brigham and Women's Hospital, Center for Cancer Research, Ninewells Hospital
- KCKrishna Chatterjee
Harvard University, Dana-Farber Cancer Institute, Inserm, Center for Cancer Research, Institut de génétique et de biologie moléculaire et cellulaire, University of Lausanne, Ninewells Hospital, Brigham and Women's Hospital
- CKChristopher K. Glass
Brigham and Women's Hospital, Ninewells Hospital, University of Lausanne, Center for Cancer Research, Harvard University, Inserm, Institut de génétique et de biologie moléculaire et cellulaire, Dana-Farber Cancer Institute
Topics & keywords
- Retinoid X receptor
- Nuclear receptor
- Peroxisome proliferator-activated receptor
- Transcription factor
- Biology
- Receptor
- Cell biology
- Response element